The_Potter
28 Jun 2019
Rebound Up to 3.4p before half year update. Unfortunately many holders will sell at this price. How much will depend on future prospects. TP
The_Potter
24 Jan 2019
Results for 2018 As there has been no posts for some time, I was wondering if anyone has any remarks on these latest results from PRM. I must admit to being pleasantly surprised. Although PRM missed out on their forecast of profitability in 2018, they do not seem to be too far off. Being the eternal optimist, I shall continue to hold. IMHO, this 20 year old startup could yet prove its worth! TP
Bowman
28 Jun 2018
AGM Trading Update JD released a AGM trading update this morning for today’s 2018 AGM. This update does not seemed to have had much effect on this morning’s drop in the SP, currently 1.3%.
Andy Reilly
06 Jun 2018
Re: Proteome Sciences says first-quarter tra... TP - Haigh has been in position fo quite while now and PRM just seems set on its usual path - I am sure many LTH's expected him to have a bit more success by now, and I am a bit surprised that there doesnt seem to be any progress. I am not sure if you followed you own advice and sold, or reduced your holding. but I just hope that, after such a long wait, you havent taken too much of a hit. It isnt good when PI's have their hopes mangled, and an investment just doesnt live up to its promise. I hope you have success elsewhere.... but PRM has been a great disappointment!
The Potter
31 May 2018
Proteome Sciences says first-quarter trading soft as expected Yesterday's trading update was hardly inspiring, especially when PRM have predicted a profit for 2018."trading so far in 2018 was 'broadly in line' with expectations amid a characteristically slow first quarter."Nothing very definite there then, except the usual PRM bombast and bluster!"we expect 2018 to be a year of progress as we develop our biomarker services business and the market for TMT strengthens"After 20 years in existence, and PRM are still developping!"While the company remains cash constrained, we have had discussions with a number of our larger shareholders who remain supportive and will provide non-dilutive funding should it be required to facilitate the evolution of the business."An admission of lack of cash, of which we are all aware.Reminds me of CP. Less exageration, but still no hope of delivering.
Andy Reilly
28 Mar 2018
Re: This company is all talk and little ... JoG - Yes its a sad story now, and many PRM investors are disillusioned with the years of poor performance, BUT I agree that Pearce (who has not acted sensibly in the past (who has?), particularly with his desire to 'talk up' the shares prospects!) He could have steered well clear of the Bio-pharma sector, and not put a lot of his funds into the sector - he at least has tried, (although all is not lost YET....) BUT it must be a painful hold, and having taken my losses with PRM some years back, I dont have the daily ritual of 'hoping' that good news at last must have arrived. All credit to Pearce, and it cant have been a pleasant time, but at least he had a go! ...AND lets just hope Haigh can salvage something and get hope and the SP returning a bit of success to PRM and to long suffering LTHs - I hope that LTH's do get their time in the sun again, so come on Haigh........ ATB
John of Groats
27 Mar 2018
Re: This company is all talk and little acti... EMike,My recollection is that Pearce's interest in Proteomics began with his child's illness and his search for a cure. As the founder of Fitness First, he had plenty of money but liitle knowledge of the causes of the illness but he was prepared to put his money into the science - hardly the ugly face of capitalism.Perhaps we should have been more wary of investing in someone's "hobby", no matter how well intentioned his motives.
EMike
27 Mar 2018
This company is all talk and little action I have held these shares for 20 years or so now and like so many of you I am totally disillusioned with all the clap-trap promises that have been made over the decades since we invested. I worked for many years in cancer research and I am well aware of the potential value of proteomics in terms of supporting tumour biomarker identification. Chris Pearce the CEO used to run around in a fancy Aston Martin car and I fear that he and his colleagues did not give a damn about the losses that we have all suffered in recent years. The UGLY face of capitalism at its worst! Their predictions and forecasts are not worth the paper they are written on today!
Andy Reilly
21 Feb 2018
Re: Broker's rating reduced TP - Unfortuntely PRM has mostly delivered disappointment in recent years, BUT at least the 7p target is double the SP now! I am not sure how they arrive at 7p! Anyway, lets hope Haigh can deliver something positive soon to at least double the SP!!! ATB
The Potter
12 Feb 2018
Broker's rating reduced finnCap today reaffirms its corporate investment rating on Proteome Sciences PLC (LON
RM) and set its price target at 7p.Disappointing. Previous rating 12p!
Andy Reilly
26 Jan 2018
Re: sp Well PRM was pretty central to my reappraisal of my approach to stocks and investing, and I sold at an 18K loss (!) way back..... I would now be nearly £25K down (near total wipe out for my holding!), and I would also have suffered the way many other LTH's have, hoping and praying that PRM could revive.... It must have been one of the worst performers in the Bio Sector over a long period, short of just going bust! The story isnt over yet, and there is always the outside chance it will recover some of its glory ..... BUT its been a long slug... and you just have to hope Haigh has seen some potential that the market has missed..... although he has now been in post for quite a while now and no sign of recovery at all. I just hope that he can revive PRM, and that next results offer some hope to very long suffering holders - ATB
Balance2
24 Jan 2018
sp I wonder if anyone remembers the days when PRM were going to inoculate every cow in the world with their wonderful markers thus ensuring a lively retirement for us all! No didn't happen but the then finance director made a packet as the sp rocketer to nearly £3, Alas I didn't sell.
dave297
20 Jan 2018
Re: John Hopkins Cancer Test Prm has been promising much & delivering wet FA for 20 years ,so,a bit like the boy who cried wolf ,maybe one day we will truly surprise The Market with truly groundbreaking news & my legacy to my kids (& 1 day maybe grandkids) will be Prm shares with some value-but I continue to not hold my breath .
The Potter
19 Jan 2018
Re: John Hopkins Cancer Test I also recently read an article on Sepsis, where biomarkers were found to give the best indication of the presence of this illness.I suppose that the SP Is unaffected by these news items, because many investors do not understand the possible implications, and those that do, are awaiting for news of profitability (promised in 2018).
i network
19 Jan 2018
John Hopkins Cancer Test "breakthrough"? This present news headline sounds like it depends on proteomics tests as well as genetic tests.I would think this could have significant impact on proteomic testing sales and services/ Why is this not affecting PRM share price??
